Validation of the severe COVID-19 prognostic value of serum IL-6, IFN-λ3, CCL17, and calprotectin considering the timing of clinical need for prediction

Although biomarkers to predict coronavirus disease 2019 (COVID-19) severity have been studied since the early pandemic, no clear guidelines on using them in clinical practice are available. Here, we examined the ability of four biomarkers to predict disease severity using conserved sera from COVID-1...

Descripción completa

Detalles Bibliográficos
Autores principales: Yamamoto, Kei, Ohsiro, Yusuke, Suzuki, Tetsuya, Suzuki, Michiyo, Miura, Sayaka, Nagashima, Maki, Iwamoto, Noriko, Takeuchi, Junko S., Kimura, Moto, Sugiura, Wataru, Nebuya, Satoru, Kurokawa, Masato, Ohmagari, Norio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062661/
https://www.ncbi.nlm.nih.gov/pubmed/36996138
http://dx.doi.org/10.1371/journal.pone.0279897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062661/
https://www.ncbi.nlm.nih.gov/pubmed/36996138
http://dx.doi.org/10.1371/journal.pone.0279897

Ejemplares similares